Why Lucid Group Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
$ABCL
$ADIL
$ARDS
$ARTW
Biotechnology: Pharmaceutical Preparations
Health Care
Biotechnology: Pharmaceutical Preparations
Health Care
Gainers
- Healthcare Triangle, Inc. (NASDAQ:HCTI) shares climbed 171.2% to $8.84 as the company launched initiative to prevent ransomware attacks in the $35 billion healthcare data market.
- Ault Alliance, Inc. (NYSE:AULT) gained 73.3% to $5.72 after the company said it anticipates $200 million in annual revenue for 2023.
- Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) shares climbed 67.3% to $11.34 after the company announced collaboration and a $50 million investment from NVIDIA.
- Cadrenal Therapeutics, Inc. (NASDAQ:CVKD) shares surged 45.1% to $2.5239 after gaining 15% on Tuesday.
- Liminal BioSciences Inc. (NASDAQ:LMNL) rose 39.6% to $8.31 after the company announced it entered into an arrangement agreement with Structured Alpha LP. Liminal minority shareholders are to receive $8.50 in cash per share in "go private" transaction.
- AVROBIO, Inc. (NASDAQ:AVRO) surged 38.8% to $1.36 after the company announced plans to explore strategic alternatives.
- LivePerson, Inc. (NASDAQ:LPSN) shares climbed 33.7% to $5.70 after the company announced a planned CEO transition.
- InspireMD, Inc. (NYSE:NSPR) gained 31% to $3.03.
- Daktronics, Inc. (NASDAQ:DAKT) rose 30.4% to $7.97 following better-than-expected fourth-quarter results.
- Freeline Therapeutics Holdings plc (NASDAQ:FRLN) shares jumped 28.7% to $4.7759.
- Society Pass Incorporated (NASDAQ:SOPA) gained 23.6% to $0.7490. Ascendiant Capital recently initiated coverage on Society Pass with a Buy rating and announced a price target of $3.5.
- Holley Inc. (NYSE:HLLY) surged 21.6% to $5.35 on positive analyst changes. B of A Securities upgraded the stock and raised its price target from $3.25 to $6, and JP Morgan upgraded the stock from Overweight to Neutral and announced a $7 price target.
- Aridis Pharmaceuticals, Inc. (NASDAQ:ARDS) rose 21% to $0.3240 after the company announced FDA Qualified Infectious Disease Product Designation for AR-301.
- Eloxx Pharmaceuticals, Inc. (NASDAQ:ELOX) gained 20.4% to $9.13. Eloxx Pharmaceuticals shares jumped 94% on Tuesday after Oppenheimer raised its price target from $50 to $55.
- AERWINS Technologies Inc. (NASDAQ:AWIN) jumped 17% to $0.55.
- Centessa Pharmaceuticals plc (NASDAQ:CNTA) rose 15.8% to $8.46. Centessa Pharmaceuticals recently announced dosing of first subject in registrational PRESent-2 study evaluating SerpinPC for the treatment of Hemophilia B without inhibitors.
- EHang Holdings Limited (NASDAQ:EH) gained 13.5% to $17.54. EHang announced a $23 million private placement led by investor Lee Soo Man.
- AbCellera Biologics Inc. (NASDAQ:ABCL) gained 13% to $7.63.
- BitNile Metaverse, Inc. (NASDAQ:BNMV) surged 12.2% to $1.1899.
- Exscientia plc (NASDAQ:EXAI) rose 12% to $7.30. Exscientia recently announced the enrollment of the first patient in the Phase 1/2 "ELUCIDATE" clinical trial assessing GTAEXS617 in advanced solid tumors.
- Domino's Pizza, Inc. (NYSE:DPZ) shares surged 10.2% to $385.54 after the company announced US customers will be able to order through Uber Eats and Postmates.
- Art's-Way Manufacturing Co., Inc. (NASDAQ:ARTW) gained 9.7% to $2.71.
- Dada Nexus Limited (NASDAQ:DADA) jumped 7.3% to $6.22.
Losers
- PainReform Ltd. (NASDAQ:PRFX) declined 44.5% to $9.00 after the company reported pricing of $2.7 million concurrent registered direct offering and private placement.
- CBL International Limited (NASDAQ:BANL) shares dipped 42.3% to $2.8780 after jumping over 12% on Tuesday.
- Katapult Holdings, Inc. (NASDAQ:KPLT) declined 27% to $0.7150. Katapult’s board approved a 1-for-25 reverse stock split of common stock.
- Silk Road Medical, Inc (NASDAQ:SILK) fell 24.4% to $24.67. Silk Road Medical is expected to report financial results for the second quarter 2023 on Aug. 1, 2023.
- Yellow Corporation (NASDAQ:YELL) dropped 21.5% to $1.0350.
- Gorilla Technology Group Inc. (NASDAQ:GRRR) fell 20% to $4.46.
- T2 Biosystems, Inc. (NASDAQ:TTOO) dropped 20% to $0.1196 as the company reported lower than expected preliminary Q2 sales of $2 million.
- Theratechnologies Inc. (NASDAQ:THTX) declined 19.5% to $0.78 following weak quarterly sales.
- Castle Biosciences, Inc. (NASDAQ:CSTL) fell 19.3% to $15.89.
- Biodexa Pharmaceuticals Plc (NASDAQ:BDRX) fell 17.7% to $4.9655 after surging 42% on Tuesday.
- Crown ElectroKinetics Corp. (NASDAQ:CRKN) fell 16.1% to $0.0913 after gaining around 7% on Tuesday.
- Jupiter Wellness, Inc. (NASDAQ:JUPW) dropped 15.4% to $0.4052. Jupiter Wellness reported postponement of spin-off and distribution of common stock of subsidiary SRM Entertainment.
- Forge Global Holdings, Inc. (NYSE:FRGE) fell 14.7% to $2.43.
- Mullen Automotive, Inc. (NASDAQ:MULN) fell 14.6% to $0.1554.
- Shengfeng Development Limited (NASDAQ:SFWL) dropped 14% to $7.87.
- ShiftPixy, Inc. (NASDAQ:PIXY) fell 13.8% to $2.06 after the company announced pricing of a $3.1 million public offering.
- CytoMed Therapeutics Limited (NASDAQ:GDTC) shares dropped 13.1% to $4.90 after climbing 62% on Tuesday.
- FLJ Group Limited (NASDAQ:FLJ) fell 12.8% to $0.2510.
- Adial Pharmaceuticals, Inc. (NASDAQ:ADIL) shares fell 11.7% to $0.34. Adial Pharmaceuticals shares jumped 90% on Tuesday after the company provided business update following favorable comments from US, EU regulatory meetings.
- Lucid Group, Inc. (NASDAQ:LCID) declined 10.9% to $7.24 after the company announced second-quarter production & deliveries.
- Cingulate Inc. (NASDAQ:CING) fell 10.4% to $0.76. Cingulate recently announced top-line results from its Phase 3 adult efficacy and safety trial of CTx-1301 for ADHD.
- WANG & LEE GROUP, Inc. (NASDAQ:WLGS) shares fell 9.7% to $1.40 after rising over 20% on Tuesday.
- COMPASS Pathways plc (NASDAQ:CMPS) fell 7.5% to $9.30.
Now Read This: Big Trades On Activision Blizzard Stock After Microsoft Wins Acquisition Case
